Get 50% OFF This Monsoon!

Advertisement
AdvertisementAdvertisement
logo

Welcure Drugs & Pharmaceuticals

524661
Micro Cap
(%) 1D
no_data

No Data Available

1D1W1M3M6M1YMAX

Investor Sentiment

50%50%
Bullish
Bearish
Advertisement
AdvertisementAdvertisement

Welcure Drugs & Pharmaceuticals Share price and Fundamental Analysis

View All Details
View All Details
Incorporated on 4 Jun.'92, Welcure Drugs And Pharmaceuticals (WDPL) was promoted by D C Jain, Sanjeev Jain and Sandeep Jain. The promoters have interests in other companies such as Paam Pharmaceuticals, Pioneer Products, Alirox Abrasives, A K Laboratories, etc.
Company Incorporation1996
ChairmanNA
Head QuartersDelhi
Previous NameNA

Key Metrics

Market Cap (Cr)
162.24
PE Ratio
75.89
Industry P/E
53.95
PEG Ratio
-0.31
ROE
2.12%
ROCE
1.23%
ROA
1.52%
Total Debt (Cr)
123.2
Debt to Equity
1.2
Dividend Yield
0%
EPS
0.19
Book Value & P/B
9.12 x 1.58
Face Value
10
Outstanding Shares(Cr)
11.25
Current Ratio
4.41
EV to Sales
6.12

Stock Returns

1 Week+20.07%
1 Month+26.71%
6 Months+0.49%
1 Year+203.58%
3 Years+79.58%
5 Years+2188.89%

CAGR

1 Year CAGR

Revenue Growth

N/A

Net Profit Growth

-271.84%

Operating Profit Growth

-232.36%

Dividend Growth

N/A

Stock Returns CAGR

+203.58%
no_data

No Stocks

Smart Score

1.7
icn

Unlock Smart Score

See Detailed Analysis & Insights

icn

Unlock Insights

See Detailed Analysis & Insights

Technicals

Returns Calculator

If you would have invested
In 5 years the current value would be
NaNCRNaNCR( %)

Research Report

No Research Report

View Other Reports >

Corporate Action

Board-Meetings
Board-Meetings
Dividends
Bonus
Splits
Right-issues
AGM-EGM
Bulk-Deal
Block-Deal

Financials

Half Yearly Statement

PARTICULARS

Total Revenue

Total Expenses

Operating Expense

Operating Profit

Interest

Depreciation & Amortization

Profit Before Tax

Tax

Profit after tax

Adj EPS in Rs - Basic

Adj EPS in Rs - Diluted

Profit and Loss Statement

Credit Rating
Director Report
Chairman Report
Auditor Report
Mar 25

Promoters : 0.00%

FIIs : 0.00%

DIIs : 0.00%

Public : 100.00%

Promoter
FII/FPI
DII
Public

Top Shareholders

View all Share Holders

Key Ratios

Profitability
Valuation
Liquidity

ROE

Avg ROE (3 Yrs) : NaN%

ROCE

Avg ROCE (3 Yrs) : NaN%

ROA

Avg ROA (3 Yrs) : NaN%

NPM

Avg NPM (3 Yrs) : NaN%

Dividend History

Welcure Drugs & Pharmaceuticals Competitors

Sector
Industry

Company Name

MCap(TTM)

PE(TTM)

P/B(TTM)

ROE(TTM)

D/E

Current Ratio(TTM)

5 Year FactSheet

Profitability
Profitability
Growth Ratios
Valuation Ratios
Cashflow Ratios
Debt and Liquidity
Efficiency Ratios

Documents

Annual Reports
Con-Call

News

Welcure Drugs & Pharmaceuticals Management and History

Company Management

icn

Unlock Management Data

See Detailed Analysis & Insights

Company History

Incorporated on 4 Jun.'92, Welcure Drugs And Pharmaceuticals (WDPL) was promoted by D C Jain, Sanjeev Jain and Sandeep Jain. The promoters have interests in other companies such as Paam Pharmaceuticals, Pioneer Products, Alirox Abrasives, A K Laboratories, etc.

WDPL had come out with a Rs 4-cr public issue in Aug.'94 to part-finance the Rs 7-cr project to manufacture bulk drugs in Rajasthan and finance investments in a subsidiary, A K Laboratories (AKL). The company has also submitted the letter of offer for a Rs 7.09-cr rights issue of equity shares in Jan.'96 to finance its expansion programmes.

Products of WDPL include bulk drugs such as ampicillin and trimethoprim, drugs intermediates and pharmaceutical formulations. It has decided to add amoxycillin and cloxacillin to its range with provision to manufacture ibuprofen. It manufactures over a hundred varieties of tablets, capsules and dry syrups, sulpha drugs, vitamins, analgesics, etc. Its subsidiary, AKL, manufactures 6-APA, a key drug intermediate in the manufacture of semi-synthetic penicillin.

The company has decided to set up new sections of paediatrics and veterinary drugs and to diversify into ointments and liquid syrups.

The new products of the company WELSTAP , X- CLOX , ETHAMBUTOL, RIFA- Z , CETIRIZIN , NORTIN have been well accepted in the market.

The Company has entered into a collaboration agreement with a russian company to act as their sole selling agent for a unique medicine Stevioside, an alternate to sugar, Saccharin and Aspartame.

The Company has added a new liquid oral plant in Bhiwadi, Rajasthan. It has obtained ISO 9002 certification with double accredition from ABS Quality Evaluation Inc Texas and by Registrar of Accredition Board of USA. Welcure has also entered into an agreement with Bihar Drugs and Chemicals Ltd, a government of Bihar undertaking, for manufacturing their products in its factory on loan basis.

During the year 2000-01 the company had launched some products like CEZEN,DIMCIN PLUS,OXIN,SPASWIN etc.The company has entered into technical collaboration agreement with Advanced Medical Care Inc New Jersey USA for setting up of joint venture facilities in the existing plant of the company.

During the year 2001-02, the company had launched products like B-ZEX, DMART PLUS, DRALPIN, DUKESPAS, DUBAMOL, HISTACURE, KUFFWEL, KINGSPAS, LANAX, PETRIMAX, PEEROSCAM, RENACT, SARVO, WELCEE, WELGESIC, WELIC, WELOXY, WELRELEEF, X-DRYL. It changed its marketing policy from 'Sales through Wholesale Distributors' to ' Sales at Doorstep' by reaching every corner of the country and by putting dual force on Sales-through sales personnel on one hand and through stockists and distributors on the other hand.

The Company is carrying on the business of manufacturers, designers, repairers, installers, merchants, importers, exporters, agent for sale and distributors of and dealers in water processing equipment and purifiers, and water softeners of every description. Apart from these, it deals in real estate and engaged in creating exceptional living and working spaces for the new Indian global professionals.

Welcure Drugs & Pharmaceuticals Share Price

Welcure Drugs & Pharmaceuticals share price reflects investor sentiment toward the company and is impacted by various factors such as financial performance, market trends, and economic conditions. Share price is an indicator which shows the current value of the company's shares at which buyers or sellers can transact.

Welcure Drugs & Pharmaceuticals Market Cap

Market capitalization of Welcure Drugs & Pharmaceuticals indicates the total value of its outstanding shares. Marketcap is calculated by multiplying share price and outstanding shares of the company. It is a helpful metric for assessing the company's size and market Valuation. It also helps investors understand how Welcure Drugs & Pharmaceuticals is valued compared to its competitors.

Welcure Drugs & Pharmaceuticals PE Ratio

Welcure Drugs & Pharmaceuticals PE ratio helps investors understand what is the market value of each stock compared to Welcure Drugs & Pharmaceuticals 's earnings. A PE ratio higher than the average industry PE could indicate an overvaluation of the stock, whereas a lower PE compared to the average industry PE could indicate an undervaluation.

Welcure Drugs & Pharmaceuticals PEG Ratio

The PEG ratio of Welcure Drugs & Pharmaceuticals evaluates its PE ratio in relation to its growth rate. A PEG ratio of 1 indicates a fair value, a PEG ratio of less than 1 indicates undervaluation, and a PEG ratio of more than 1 indicates overvaluation.

Welcure Drugs & Pharmaceuticals ROE (Return on Equity)

Return on Equity (ROE) measures how effectively Welcure Drugs & Pharmaceuticals generates profit from shareholders' equity. A higher ROE of more than 20% indicates better financial performance in terms of profitability.

Welcure Drugs & Pharmaceuticals ROCE (Return on Capital Employed)

Return on Capital Employed (ROCE) evaluates the profitability of Welcure Drugs & Pharmaceuticals in relation to its capital employed. In simple terms, ROCE provides insight to investors as to how well the company is utilizing the capital deployed. A high ROCE of more than 20% shows that the business is making profitable use of its capital.

Welcure Drugs & Pharmaceuticals Total Debt

Total debt of Welcure Drugs & Pharmaceuticals shows how much the company owes to either banks or individual creditors. In simple terms, this is the amount the company has to repay. Total debt can be a very useful metric to show the financial health of the company. Total debt more than equity is considered to be a bad sign.

Welcure Drugs & Pharmaceuticals Debt to Equity Ratio

The Debt-to-Equity (DE) ratio of Welcure Drugs & Pharmaceuticals compares its total debt to shareholders' equity. A higher Debt to Equity ratio could indicate higher financial risk, while a lower ratio suggests that the company is managing its debt efficiently.

Welcure Drugs & Pharmaceuticals CAGR (Compound Annual Growth Rate)

CAGR shows the consistent growth rate of Welcure Drugs & Pharmaceuticals over a specific period, whether it is over a month, a year, or 10 years. It is a key metric to evaluate the company’s long-term growth potential. Main metrics for which CAGR is calculated are net sales, net profit, operating profit, and stock returns.

Welcure Drugs & Pharmaceuticals Technical Analysis

Technical analysis of Welcure Drugs & Pharmaceuticals helps investors get an insight into when they can enter or exit the stock. Key components of Welcure Drugs & Pharmaceuticals Technical Analysis include:

Support Levels (S1, S2, S3)

There are usually multiple support levels, but the main support levels for a stock are S1, S2, S3. Support levels indicate price points where stock might get support from buyers, helping the stock stop falling and rise.

Resistance Levels (R1, R2, R3)

There are usually multiple resistance levels, but the main resistance levels for a stock are R1, R2, R3. Resistance levels represent price points where Welcure Drugs & Pharmaceuticals shares often struggle to rise above due to selling pressure.

Welcure Drugs & Pharmaceuticals Dividends

Dividends refer to the portion of the company’s profits distributed to its shareholders. Dividends are typically paid out in cash and reflect Welcure Drugs & Pharmaceuticals ’s financial health and profitability.

Welcure Drugs & Pharmaceuticals Bonus Shares

Bonus shares are usually given by companies to make the stock more affordable, increase liquidity, boost investor confidence, and more.

Welcure Drugs & Pharmaceuticals Stock Split

Stock split increases the number of its outstanding shares by dividing each existing share into multiple shares. When the company offers a stock split, the face value of the stock reduces in the same proportion as the split ratio.

Welcure Drugs & Pharmaceuticals Financials

The financials of Welcure Drugs & Pharmaceuticals provide a complete view to investors about its net sales, net profit, operating profits, expenses, and overall financial health. Investors can analyze financial data to assess the company’s stability and also understand how the company has been growing financially.

Welcure Drugs & Pharmaceuticals Profit and Loss Statements

The profit and loss statement of Welcure Drugs & Pharmaceuticals highlights its net sales, net profit, total expenditure, and operating profits in the current financial year. This Profit and Loss statement is crucial for evaluating the profitability and financial stability of Welcure Drugs & Pharmaceuticals .

Welcure Drugs & Pharmaceuticals Balance Sheet

The balance sheet presents a snapshot of Welcure Drugs & Pharmaceuticals ’s assets, liabilities, and equity of shareholders, providing insights into the financials of the company.

Welcure Drugs & Pharmaceuticals Cashflow Statements

Cashflow statements track the company's cash inflows and outflows over a period. It is an essential tool for understanding how well the company manages its liquidity and finances.

Download the App

Download the App